Danielle Tatum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Danielle Tatum has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Sharven Taghavi
Department of Surgery, Tulane University School of Medicine, New Orleans, La
6 shared publications - Juan Duchesne
Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana
5 shared publications - Patrick McGrew
Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana
4 shared publications - Christofer Anderson
Tulane University School of Medicine
2 shared publications David Yu
Tulane University School of Medicine, Department of Surgery, 1430 Tulane Avenue, New Orleans, LA 70112, USA; Manning Family Children's Hospital, Department of Surgery, 200 Henry Clay Avenue, New Orleans, LA 70118, USA
2 shared publications- Elliot Richard Haut
Division of Acute Care Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
2 shared publications
Latest Publications
- Open Access
- 3 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (6) , 163047
Angioembolization versus surgical repair in pediatric liver trauma: A propensity score–matched analysis of TQIP data
- 3 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (6) , 163047
Open AccessAngioembolization versus surgical repair in pediatric liver trauma: A propensity score–matched analysis of TQIP data
- 4 June 2025
- Published by Elsevier in Journal of Surgical Research
- Vol. 311, 306-314
Association of Housing Instability With Firearm Homicides in Major US Cities
- 4 June 2025
- Published by Elsevier in Journal of Surgical Research
- Vol. 311, 306-314
Association of Housing Instability With Firearm Homicides in Major US Cities
- Open Access
- 27 March 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (6) , 162296
Cost Effectiveness of Pediatric Blunt Cerebrovascular Injury Screening: A Decision Tree Analysis
- 27 March 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (6) , 162296
Open AccessCost Effectiveness of Pediatric Blunt Cerebrovascular Injury Screening: A Decision Tree Analysis
- Open Access
- 19 August 2023
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 34 (1) , 76-86
Nutritional Considerations for Patients With Renal Failure Undergoing Sleeve Gastrectomy
- 19 August 2023
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 34 (1) , 76-86
Open AccessNutritional Considerations for Patients With Renal Failure Undergoing Sleeve Gastrectomy
- Open Access
- 10 June 2022
- Published by Louisiana State University Libraries
Identification of Novel Core and Accessory Factors Involved in Nucleotide Excision Repair in Yeast
Nucleotide excision repair (NER) is a highly conserved DNA repair mechanism which deals with a wide variety of bulky, helix-distorting lesions, such as UV-induced cyclobutane pyrimidine dimers (CPDs). NER is traditionally grouped into two pathways: global genomic repair (GGR), which is operative throughout the genome, and transcription coupled repair (TCR), which is dedicated to rapid repair of the transcribed strand of actively transcribed genes. Though most of the core NER proteins are known, the exact biochemical mechanism of eukaryotic NER remains elusive. This dissertation focused on identifying novel core and accessory factors which function in NER. In the budding yeast Saccharomyces cerevisiae, GGR has previously been shown to be dependent on Rad7 and Rad16. We revealed Elc1, the yeast homolog of human elongin C, as a novel GGR-specific factor. Elc1 is required for GGR, but has no role in TCR. The precise role of Elc1 in GGR remains unknown. Dot1 is a histone methyltransferase whose sole substrate is histone H3 lysine 79 (H3K79). We identified Dot1 as another GGR-specific factor, as deletion of Dot1 or mutation of H3K79 abolishes GGR, but has no effect on TCR. H3K79 can accept up to 3 methyl groups, but Dot1 can only add one by itself. The PAF transcription elongation complex, through facilitating histone modifications, is partially required for dimethylation and fully required for trimethylation of H3K79 by Dot1. We demonstrated that through facilitating these histone modifications, PAF is partially required for GGR. TCR is believed to be triggered by a stalled elongating RNA polymerase II (Pol II) complex. Rad26, the homolog of the human CSB gene, and Rpb9, a nonessential subunit of Pol II, play important roles in TCR. We identified a dual role for PAF in TCR. In the presence of Rad26, PAF plays a positive role, facilitating TCR. In the absence of Rad26, PAF functions as a suppressor of TCR. PAF appears to be a part of a “megasuppressor” complex which includes Rpb4 and the Spt4/Spt5 complex, which also suppress Rad26-independent TCR. The interactions among Pol II, Rad26 and the various TCR suppressors remain to be elucidated.
- 10 June 2022
- Published by Louisiana State University Libraries
Open AccessIdentification of Novel Core and Accessory Factors Involved in Nucleotide Excision Repair in Yeast
Nucleotide excision repair (NER) is a highly conserved DNA repair mechanism which deals with a wide variety of bulky, helix-distorting lesions, such as UV-induced cyclobutane pyrimidine dimers (CPDs). NER is traditionally grouped into two pathways: global genomic repair (GGR), which is operative throughout the genome, and transcription coupled repair (TCR), which is dedicated to rapid repair of the transcribed strand of actively transcribed genes. Though most of the core NER proteins are known, the exact biochemical mechanism of eukaryotic NER remains elusive. This dissertation focused on identifying novel core and accessory factors which function in NER. In the budding yeast Saccharomyces cerevisiae, GGR has previously been shown to be dependent on Rad7 and Rad16. We revealed Elc1, the yeast homolog of human elongin C, as a novel GGR-specific factor. Elc1 is required for GGR, but has no role in TCR. The precise role of Elc1 in GGR remains unknown. Dot1 is a histone methyltransferase whose sole substrate is histone H3 lysine 79 (H3K79). We identified Dot1 as another GGR-specific factor, as deletion of Dot1 or mutation of H3K79 abolishes GGR, but has no effect on TCR. H3K79 can accept up to 3 methyl groups, but Dot1 can only add one by itself. The PAF transcription elongation complex, through facilitating histone modifications, is partially required for dimethylation and fully required for trimethylation of H3K79 by Dot1. We demonstrated that through facilitating these histone modifications, PAF is partially required for GGR. TCR is believed to be triggered by a stalled elongating RNA polymerase II (Pol II) complex. Rad26, the homolog of the human CSB gene, and Rpb9, a nonessential subunit of Pol II, play important roles in TCR. We identified a dual role for PAF in TCR. In the presence of Rad26, PAF plays a positive role, facilitating TCR. In the absence of Rad26, PAF functions as a suppressor of TCR. PAF appears to be a part of a “megasuppressor” complex which includes Rpb4 and the Spt4/Spt5 complex, which also suppress Rad26-independent TCR. The interactions among Pol II, Rad26 and the various TCR suppressors remain to be elucidated.
- 30 May 2022
- Published by Elsevier in The Lancet Haematology
- Vol. 9 (6) , e396-e397
Prehospital blood transfusion for haemorrhagic shock
- 30 May 2022
- Published by Elsevier in The Lancet Haematology
- Vol. 9 (6) , e396-e397
Prehospital blood transfusion for haemorrhagic shock
- 17 March 2022
- Published by Elsevier in Journal of Surgical Research
- Vol. 275, 194-202
Thromboembolic Outcomes in Tetrahydrocannabinol-Positive Trauma Patients With Traumatic Brain Injury
- 17 March 2022
- Published by Elsevier in Journal of Surgical Research
- Vol. 275, 194-202
Thromboembolic Outcomes in Tetrahydrocannabinol-Positive Trauma Patients With Traumatic Brain Injury
- 1 November 2021
- Published by Elsevier in Journal of the American College of Surgeons
- Vol. 233 (5) , e203-e204
An Eastern Association for the Surgery of Trauma Multicenter Trial of Prehospital Procedures in Penetrating Trauma: Are Tourniquets Justified?
- 1 November 2021
- Published by Elsevier in Journal of the American College of Surgeons
- Vol. 233 (5) , e203-e204
An Eastern Association for the Surgery of Trauma Multicenter Trial of Prehospital Procedures in Penetrating Trauma: Are Tourniquets Justified?
- 12 March 2021
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 91 (1) , 154-163
The burden of readmission after discharge from necrotizing soft tissue infection
BACKGROUND: The need for extensive surgical debridement with necrotizing soft tissue infections (NSTIs) may put patients at high risk for unplanned readmission. However, there is a paucity of data on the burden of readmission in patients afflicted with NSTI. We hypothesized that unplanned readmission would significantly contribute to the burden of disease after discharge from initial hospitalization. METHODS: The Nationwide Readmission Database was used to identify adults undergoing debridement for NSTI hospitalizations from 2010 to 2017. Risk factors for 90-day readmission were assessed by Cox proportional hazards regression. RESULTS: There were a total of 82,738 NSTI admissions during the study period, of which 25,076 (30.3%) underwent 90-day readmissions. Median time to readmission was 25 days (interquartile range, 9–49 days). Fragmentation of care, longer length of index stay (>2 weeks), and Medicaid status were independent risk factors for readmission. Median cost of a readmission was US $10,543. Readmission added 174,640 hospital days to episodes of care over the study period, resulting in an estimated financial burden of US $1.4 billion. CONCLUSION: Unplanned readmission caused by NSTIs is common and costly. Interventions that target patients at risk for readmission may help decrease the burden of disease. LEVEL OF EVIDENCE: Economic/Epidemiological, level IV.
- 12 March 2021
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 91 (1) , 154-163
The burden of readmission after discharge from necrotizing soft tissue infection
BACKGROUND: The need for extensive surgical debridement with necrotizing soft tissue infections (NSTIs) may put patients at high risk for unplanned readmission. However, there is a paucity of data on the burden of readmission in patients afflicted with NSTI. We hypothesized that unplanned readmission would significantly contribute to the burden of disease after discharge from initial hospitalization. METHODS: The Nationwide Readmission Database was used to identify adults undergoing debridement for NSTI hospitalizations from 2010 to 2017. Risk factors for 90-day readmission were assessed by Cox proportional hazards regression. RESULTS: There were a total of 82,738 NSTI admissions during the study period, of which 25,076 (30.3%) underwent 90-day readmissions. Median time to readmission was 25 days (interquartile range, 9–49 days). Fragmentation of care, longer length of index stay (>2 weeks), and Medicaid status were independent risk factors for readmission. Median cost of a readmission was US $10,543. Readmission added 174,640 hospital days to episodes of care over the study period, resulting in an estimated financial burden of US $1.4 billion. CONCLUSION: Unplanned readmission caused by NSTIs is common and costly. Interventions that target patients at risk for readmission may help decrease the burden of disease. LEVEL OF EVIDENCE: Economic/Epidemiological, level IV.